Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
Caroline Brenner Thomsen, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Heidi Ryssel, Ina Mathilde Kjær, Karen Lycke Wind, Louise Bach Callesen, Louise Faaborg, Malene S. Frank, Rikke Fredslund Andersen, Karen‐Lise Garm Spindler, Anders Jakobsen
Abstract
This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.
Topics & Concepts
MedicineCirculating tumor DNAOncologyStandardizationCancerInternal medicineLawPolitical scienceCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsPancreatic and Hepatic Oncology Research